Cargando…
Surgery Should Complement Endocrine Therapy for Elderly Postmenopausal Women with Hormone Receptor-Positive Early-Stage Breast Cancer
Introduction. Endocrine therapy (ET) is an integral part of breast cancer (BC) treatment with surgical resection remaining the cornerstone of curative treatment. The objective of this study is to compare the survival of elderly postmenopausal women with hormone receptor-positive early-stage BC treat...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434381/ https://www.ncbi.nlm.nih.gov/pubmed/22970358 http://dx.doi.org/10.1155/2012/180574 |
_version_ | 1782242432294846464 |
---|---|
author | Nguyen, Olivier Sideris, Lucas Drolet, Pierre Gagnon, Marie-Claude Leblanc, Guy Leclerc, Yves E. Mitchell, Andrew Dubé, Pierre |
author_facet | Nguyen, Olivier Sideris, Lucas Drolet, Pierre Gagnon, Marie-Claude Leblanc, Guy Leclerc, Yves E. Mitchell, Andrew Dubé, Pierre |
author_sort | Nguyen, Olivier |
collection | PubMed |
description | Introduction. Endocrine therapy (ET) is an integral part of breast cancer (BC) treatment with surgical resection remaining the cornerstone of curative treatment. The objective of this study is to compare the survival of elderly postmenopausal women with hormone receptor-positive early-stage BC treated with ET alone, without radiation or chemotherapy, versus ET plus surgery. Materials and Methods. This is a retrospective study based on a prospective database. The medical records of postmenopausal BC patients referred to the surgical oncology service of two hospitals during an 8-year period were reviewed. All patients were to receive ET for a minimum of four months before undergoing any surgery. Results. Fifty-one patients were included and divided in two groups, ET alone and ET plus surgery. At last follow-up in exclusive ET patients (n = 28), 39% had stable disease or complete response, 22% had progressive disease, of which 18% died of breast cancer, and 39% died of other causes. In surgical patients (n = 23), 78% were disease-free, 9% died of recurrent breast cancer, and 13% died of other causes. Conclusions. These results suggest that surgical resection is beneficial in this group and should be considered, even for patients previously deemed ineligible for surgery. |
format | Online Article Text |
id | pubmed-3434381 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-34343812012-09-11 Surgery Should Complement Endocrine Therapy for Elderly Postmenopausal Women with Hormone Receptor-Positive Early-Stage Breast Cancer Nguyen, Olivier Sideris, Lucas Drolet, Pierre Gagnon, Marie-Claude Leblanc, Guy Leclerc, Yves E. Mitchell, Andrew Dubé, Pierre Int J Surg Oncol Clinical Study Introduction. Endocrine therapy (ET) is an integral part of breast cancer (BC) treatment with surgical resection remaining the cornerstone of curative treatment. The objective of this study is to compare the survival of elderly postmenopausal women with hormone receptor-positive early-stage BC treated with ET alone, without radiation or chemotherapy, versus ET plus surgery. Materials and Methods. This is a retrospective study based on a prospective database. The medical records of postmenopausal BC patients referred to the surgical oncology service of two hospitals during an 8-year period were reviewed. All patients were to receive ET for a minimum of four months before undergoing any surgery. Results. Fifty-one patients were included and divided in two groups, ET alone and ET plus surgery. At last follow-up in exclusive ET patients (n = 28), 39% had stable disease or complete response, 22% had progressive disease, of which 18% died of breast cancer, and 39% died of other causes. In surgical patients (n = 23), 78% were disease-free, 9% died of recurrent breast cancer, and 13% died of other causes. Conclusions. These results suggest that surgical resection is beneficial in this group and should be considered, even for patients previously deemed ineligible for surgery. Hindawi Publishing Corporation 2012 2012-08-27 /pmc/articles/PMC3434381/ /pubmed/22970358 http://dx.doi.org/10.1155/2012/180574 Text en Copyright © 2012 Olivier Nguyen et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Nguyen, Olivier Sideris, Lucas Drolet, Pierre Gagnon, Marie-Claude Leblanc, Guy Leclerc, Yves E. Mitchell, Andrew Dubé, Pierre Surgery Should Complement Endocrine Therapy for Elderly Postmenopausal Women with Hormone Receptor-Positive Early-Stage Breast Cancer |
title | Surgery Should Complement Endocrine Therapy for Elderly Postmenopausal Women with Hormone Receptor-Positive Early-Stage Breast Cancer |
title_full | Surgery Should Complement Endocrine Therapy for Elderly Postmenopausal Women with Hormone Receptor-Positive Early-Stage Breast Cancer |
title_fullStr | Surgery Should Complement Endocrine Therapy for Elderly Postmenopausal Women with Hormone Receptor-Positive Early-Stage Breast Cancer |
title_full_unstemmed | Surgery Should Complement Endocrine Therapy for Elderly Postmenopausal Women with Hormone Receptor-Positive Early-Stage Breast Cancer |
title_short | Surgery Should Complement Endocrine Therapy for Elderly Postmenopausal Women with Hormone Receptor-Positive Early-Stage Breast Cancer |
title_sort | surgery should complement endocrine therapy for elderly postmenopausal women with hormone receptor-positive early-stage breast cancer |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434381/ https://www.ncbi.nlm.nih.gov/pubmed/22970358 http://dx.doi.org/10.1155/2012/180574 |
work_keys_str_mv | AT nguyenolivier surgeryshouldcomplementendocrinetherapyforelderlypostmenopausalwomenwithhormonereceptorpositiveearlystagebreastcancer AT siderislucas surgeryshouldcomplementendocrinetherapyforelderlypostmenopausalwomenwithhormonereceptorpositiveearlystagebreastcancer AT droletpierre surgeryshouldcomplementendocrinetherapyforelderlypostmenopausalwomenwithhormonereceptorpositiveearlystagebreastcancer AT gagnonmarieclaude surgeryshouldcomplementendocrinetherapyforelderlypostmenopausalwomenwithhormonereceptorpositiveearlystagebreastcancer AT leblancguy surgeryshouldcomplementendocrinetherapyforelderlypostmenopausalwomenwithhormonereceptorpositiveearlystagebreastcancer AT leclercyvese surgeryshouldcomplementendocrinetherapyforelderlypostmenopausalwomenwithhormonereceptorpositiveearlystagebreastcancer AT mitchellandrew surgeryshouldcomplementendocrinetherapyforelderlypostmenopausalwomenwithhormonereceptorpositiveearlystagebreastcancer AT dubepierre surgeryshouldcomplementendocrinetherapyforelderlypostmenopausalwomenwithhormonereceptorpositiveearlystagebreastcancer |